Kim, K. H., Jelovac, D., Armstrong, D. K., Schwartz, B., Weil, S. C., Schweizer, C., & Alvarez, R. D. (2015). Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer(,,). Gynecol Oncol.
シカゴスタイル引用形Kim, Kenneth H., Danijela Jelovac, Deborah K. Armstrong, Benjamin Schwartz, Susan C. Weil, Charles Schweizer, , Ronald D. Alvarez. "Phase 1b Safety Study of Farletuzumab, Carboplatin and Pegylated Liposomal Doxorubicin in Patients With Platinum-sensitive Epithelial Ovarian Cancer(,,)." Gynecol Oncol 2015.
MLA引用形式Kim, Kenneth H., et al. "Phase 1b Safety Study of Farletuzumab, Carboplatin and Pegylated Liposomal Doxorubicin in Patients With Platinum-sensitive Epithelial Ovarian Cancer(,,)." Gynecol Oncol 2015.